跳至主要内容
临床试验/NL-OMON26364
NL-OMON26364已完成3 期

Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis

Maastricht University Medical Center (MUMC+)0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Adult ; Objectively confirmed DVT of lower extremity by DUS; Proximal localisation of DVT; Acute onset of DVT (symptoms for = 7 days at presentation); Willing and able to give written consent

排除标准

  • Previous DVT; Bilateral DVT; Pre-existent chronic venous insufficiency; Active malignancy or inflammatory disease; Pregnancy; Indication for therapeutic thrombolysis; Contra-indication for DOAC

研究者

发起方
Maastricht University Medical Center (MUMC+)

相似试验